Grants

Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.

Filter By

Year

Topic

Location

Displaying 1 - 1 of 1 results

A Randomized Trial Comparing Treatment Completion of Daily Rifapentine & Isoniazid for One Month (1HP) To Weekly Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in HIV-negative Household Contacts of Recently Diagnosed Tuberculosis Cases

Date:

07/19/2023
Locations:
Topics:
- HIV/AIDS
- Global Health
Lead Investigators:
- Richard E. Chaisson, MD